Understand the source comparison
Lyophilised Stability Claims Versus Cold Chain Reality
The second major myth: that lyophilised (freeze-dried) peptides are shelf-stable at room temperature indefinitely as long as the vial remains sealed. This claim appears in supplier FAQs, shipping policy pages, and even some product listings for compounds like
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The second major myth: that lyophilised (freeze-dried) peptides are shelf-stable at room temperature indefinitely as long as the vial remains sealed. This claim appears in supplier FAQs, shipping policy pages, and even some product listings for compounds like MK 677 and Hexarelin. It's technically true for some peptides under some conditions. And catastrophically false for others. Lyophilisation removes water, which dramatically slows hydrolytic degradation, but it does not stop oxidation, deamidation, or aggregation. Peptides with methionine, cysteine, tryptophan, or asparagine residues degrade even in solid state at ambient temperature. The degradation rate depends on the sequence, the residual moisture content post-lyophilisation, and the storage temperature. A vial stored at 25°C for six months may show 85–90% of the original peptide remaining by HPLC. But the 10–15% that degraded may have formed aggregates or oxidised species that interfere with your assay.
- Data from pharmaceutical stability studies show that most therapeutic peptides maintain >95% purity for 24 months at −20°C, 12–18 months at 2–8°C, but only 3–6 months at room temperature (20–25°C). And those figures assume low humidity and light protection. If your lab received a lyophilised peptide shipment that sat on a loading dock for eight hours at 30°C in July, then sat in a storage cabinet at ambient temperature for four months before use, the KLOW myths cost money health impact is already baked in before reconstitution. The peptide may look fine. It's still a white powder. But the potency and purity have drifted. Assays will show weaker-than-expected activity, higher variability, or unexplained baseline signal. We've guided labs through this exact troubleshooting process. The solution is cold chain verification and immediate −20°C storage upon receipt, not assumptions based on 'it's lyophilised, it's fine.'